Disaster and Multiple Sclerosis: A Systematic Review

Background

Multiple Sclerosis (MS) patients experience a variety of disease caused disabilities that makes them more vulnerable to the effects of disasters. This study aimed to review all existed studies about disasters and related disaster management planning about MS patients.

Methods

The PubMed, Google Scholar, Scopus, and Web of Science, ProQuest, science direct , and grey literature databases were searched up to the mid of 2021. All obtained titles were assessed by the inclusion criteria. Abstracts of the relevant titles were reviewed and eligible articles/documents were included for full text review and data abstraction.

Results

From 24616 Articles/documents, finally 15 documents (13 articles, and 2 books) were selected. In 8 articles (53%) specifically, focused on MS patients and, in the rest focused on them as a member of people with disabilities. Most studies (10, 71.4%), emphasized on the disaster induced stress effect on MS patients. In two books/book sections, the disaster preparedness plan for all types of disabilities was presented in general, and MS patients were mentioned as a member of the group of patients with disabilities.

Conclusion

Despite the importance of planning in response to disasters to address specific problems of MS patients, there is a lack of proper planning. This is very important and there is an urgent need to develop appropriate planning protocols for addressing the special conditions of MS patients in response to disasters.

Measures to Control Covid-19 Epidemic in Public and Reduce the Patient Load in Hospitals: A Report From Iran

After presenting the novel coronavirus (SARS-CoV-2) in china, it has spread rapidly in the community and now has declared as a pandemic causing coronavirus disease 2019 (COVID-19). At the date of writing this report, the COVID-19 has affected 192 countries and one international conveyance (the Diamond Princess cruise ship harbored in Yokohama, Japan) around the world with the total cases of 341,529. In Iran, the emergence of the disease was reported with two cases of COVID-19 deaths in Qom city on February 19, 2020, that caused great concern for the health system and the general public. It was rapidly spread around the country and reach to 21,638 definite cases by March 22, 2020. The special nature of the disease in rapid transmission among individuals in society requires urgent measures and serious actions to control it as quickly as possible. In this report, we describe the current status of the COVID-19 response strategy for reducing transmission in public and patient load in hospitals in Iran. Although Iran has tried to use the successful experience of other countries, such as China, for various reasons, such as non-quarantine of Qom province, as the primary site of disease propagation, lack of public quarantine, lack of seriousness by some citizens and officials, the lack of facilities and personal protective equipment needed for staff use, and restrictions regarding purchasing equipment from other countries due to international sanctions, have served as obstacles to achieve good results.

Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018

BACKGROUND

Information of Previous studies on the prevalence of MS, including our study conducted 12 years ago, used to shape global prevalence map of MS. According to those results, Iran placed in medium-prevalence MS region in the world Atlas of MS 2013.This study aimed to investigate the prevalence of MS in Mazandaran province after 12 years and the need for possible changes in the global map of the prevalence of MS.

METHODS

We included all MS patients living in Mazandaran province in 2018 in this descriptive cross-sectional study. We updated our pre-existing registration questionnaires which included demographic information and medical data of MS patients by interview. We obtained the demographic profile of Mazandaran province from the most recent census in 2016 and the National Civil Registry of the Mazandaran province for calculating prevalence of MS.

RESULTS

The total number of MS patients in Mazandaran was 2418 (25.8% male and 74.2% female) with a female to male ratio of 2.9. Based on the local population of 3,332,556, (50.4% male and 49.6% female), this study showed a prevalence of 72.5 per 100,000 for MS in this region. The prevalence of this disease by gender was 37.1 per 100,000 for men and 108.5 per 100,000 for women. The mean (SD) age of the patients at the time of the study was 38.5 (10.1) years with a minimum of 15 and a maximum of 75 years. The most common type of MS was Relapsing-Remitting MS with 86%.

CONCLUSIONS

All recent studies showed significant upward trend in the prevalence of MS around the world. Based on the results of our study and many other studies in Iran, the Atlas of MS prevalence map needs to be update. Iran's status should be changed to the high-prevalence of MS in the new Atlas. Due to the increasing prevalence of MS, we suggest an adjustment in the Global MS Prevalence Scale.